
Gofor MV 1mg/500mg/0.2mg Tablet SR
Marketer
Diabocare Pharmaceuticals
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Gofor MV 1mg/500mg/0.2mg Tablet SR
Diabetol Trio 1mg/500mg/0.2mg Extended-Release Tablets are classified as anti-diabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, helping regulate blood glucose. Diabetol Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, encompassing dietary modifications, regular physical activity, and weight management as directed by your doctor. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to identify its symptoms, including sweating, vertigo, cephalalgia, and tremors, and implement appropriate countermeasures. Regular meals and carrying a quick-acting glucose source (e.g., sugary snacks or juice) are preventative measures. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use if pregnant or breastfeeding. Regular blood glucose monitoring is essential; additional blood tests may be recommended to track blood cell counts and liver function.
Uses of Gofor MV 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Gofor MV 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer Gofor MV 1mg/500mg/0.2mg Extended-Release tablets on an empty stomach.
Common Side effects of Gofor MV 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Gofor MV 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Gofor MV 1mg/500mg/0.2mg sustained-release tablet should be administered on an empty stomach.
How Gofor MV 1mg/500mg/0.2mg Tablet SR works:
Gofor MV extended-release tablets (1 mg/500 mg/0.2 mg) contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Gofor MV 1mg/500mg/0.2mg SR tablets is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Gofor MV 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Gofor MV 1mg/500mg/0.2mg tablet likely poses a risk during lactation. Available human data indicates potential transfer to breast milk, with the possibility of infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Gofor MV 1mg/500mg/0.2mg Tablet SR is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is necessary. Furthermore, this medication is contraindicated in patients exhibiting severe renal dysfunction.
LiverCAUTION
Patients with liver impairment should use Gofor MV 1mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. Individuals with mild to moderate liver disease should begin with a low dose; however, its use is contraindicated in those with severe hepatic dysfunction. Physician consultation is advised.
What if you forget to take Gofor MV 1mg/500mg/0.2mg Tablet SR :
Should you forget to take your Gofor MV 1mg/500mg/0.2mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gofor MV 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
